Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - OMEGA PROTEIN CORP | d247001dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Act of 1934
Date of Report (Date of earliest event reported): October 24, 2011
Omega Protein Corporation
(Exact name of registrant as specified in its charter)
| Nevada |
001-14003 |
76-0562134 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
| 2105 City West Blvd., Suite 500 Houston, Texas |
77042 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(713) 623-0060
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CRF 240.133-4(c)) |
Item 8.01. Other Events
On October 24, 2011, Omega Protein Corporation (the “Company”) issued a press release announcing the retention of Lipid Technologies, LLC. For additional information, please refer to the Company’s press release attached to this report as Exhibit 99.1 and incorporated herein by reference.
In accordance with General Instructions B.2 and B.6 of Form 8-K, the foregoing information, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information and Exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
In accordance with
Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits
| (a) | Financial Statements of business acquired. |
None.
| (b) | Pro Forma Financial Information. |
None.
| (c) | Shell Company Transactions. |
None.
| (d) | Exhibits. |
| 99.1 | Text of Press Release dated October 24, 2011 titled “Omega Protein Announces Retention of Lipid Technologies, LLC.” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Omega Protein Corporation | ||||
| Date: October 24, 2011 | /s/ John D. Held | |||
| John D. Held | ||||
| Executive Vice President and | ||||
| General Counsel | ||||